E-LIB Suche - Ergebnisse für: Locker, G.J.

1

Epicure: a European epidemiological study of patients with ..:

Houédé, N. ; Locker, G. ; Lucas, C....
BMC Cancer. 16 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

2

2627 Characteristics and treatments patterns of patients wi..:

Houede, N. ; Locker, G.J. ; Lucas, C....
European Journal of Cancer. 51 (2015) - p. S521 , 2015

Link: https://doi.org/10.1016/..

3

Langzeitanwendung eines intravasalen Temperaturkatheters:

Krizanac, D. ; Bojic, A. ; Rabitsch, W....
Medizinische Klinik - Intensivmedizin und Notfallmedizin. 109 (2014) 3 - p. 200-204 , 2014

Link: https://doi.org/10.1007/..

4

The use of Drotrecogin Alfa in Severe Falciparum Malaria:

Robak, O. ; Bojic, A. ; Locker, G. J....
Anaesthesia and Intensive Care. 38 (2010) 4 - p. 751-754 , 2010

Link: https://doi.org/10.1177/..

5

198 INCIDENCE, CAUSES AND OUTCOME OF HYPOXIC HEPATITIS:

Fuhrmann, V. ; Kneidinger, N. ; Locker, G....
Journal of Hepatology. 48 (2008) - p. S83 , 2008

Link: https://doi.org/10.1016/..

6

Single-dose pharmacokinetics of cefodizime in critically il..:

MEYER, B ; TRAUNMUELLER, F ; BOJIC, A...
International Journal of Antimicrobial Agents. 27 (2006) 4 - p. 335-338 , 2006

Link: https://doi.org/10.1016/..

7

Fulvestrant ('Faslodex') in pre-treated patients with advan..:

Steger, G.G. ; Bartsch, R. ; Wenzel, C....
European Journal of Cancer. 41 (2005) 17 - p. 2655-2661 , 2005

Link: https://doi.org/10.1016/..

8

The Foresight Vehicle: Prescient Tools to Support the Desig..:

Strutt, J. E. ; Hall, P. L. ; Georgiou, S....
SAE Transactions. 111 (2002) - p. 455-466 , 2002

Link: https://www.jstor.org/st..

9

Pilot study with pegylated liposomal doxorubicin for advanc..:

Schmidinger, M ; Wenzel, C ; Locker, G J...
British Journal of Cancer. 85 (2001) 12 - p. 1850-1852 , 2001

Link: https://doi.org/10.1054/..

10

The efficacy of chemoradiation therapy in HIV seropositive ..:

Efron, J. E. ; Pikarsky, A. J. ; Gervaz, P....
Colorectal Disease. 3 (2001) 6 - p. 402-405 , 2001

Link: https://doi.org/10.1046/..

11

Penetration of capecitabine and its metabolites into malign..:

Mader, R.M. ; Schrolnberger, C. ; Rizovski, B....
European Journal of Cancer. 37 (2001) - p. S18 , 2001

Link: https://doi.org/10.1016/..

12

Use of abciximab-Modified Thrombelastography in Patients Un..:

Kettner, S. C. ; Panzer, O. P. ; Kozek, S. A....
Anesthesia & Analgesia. 89 (1999) 3 - p. 580 , 1999

Link: https://doi.org/10.1213/..

13

CONTINUOUS VERSUS INTERMITTENT MEROPENEM ADMINISTRATION IN ..:

Thalhammer, F. ; Traunmuller, F. ; Hollenstein, U.M....
Critical Care Medicine. 27 (1999) Supplement - p. 139A , 1999

Link: https://doi.org/10.1097/..

14

Use of abciximab-Modified Thrombelastography in Patients Un..:

Kettner, S. C. ; Panzer, O. P. ; Kozek, S. A....
Anesthesia & Analgesia. 89 (1999) 3 - p. 580 , 1999

Link: https://doi.org/10.1097/..

15

Continuous infusion versus intermittent administration of m..:

Thalhammer, F. ; Traunmuller, F. ; El Menyawi, I....
Journal of Antimicrobial Chemotherapy. 43 (1999) 4 - p. 523-527 , 1999

Link: https://doi.org/10.1093/..